GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Flerie AB (OSTO:FLERIE) » Definitions » Cyclically Adjusted Price-to-FCF

Flerie AB (OSTO:FLERIE) Cyclically Adjusted Price-to-FCF : (As of Jun. 07, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Flerie AB Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Flerie AB Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Flerie AB's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Flerie AB Cyclically Adjusted Price-to-FCF Chart

Flerie AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Flerie AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Flerie AB's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Flerie AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Flerie AB's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Flerie AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Flerie AB's Cyclically Adjusted Price-to-FCF falls into.


;
;

Flerie AB Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Flerie AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Flerie AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.233/132.8245*132.8245
=-0.233

Current CPI (Mar. 2025) = 132.8245.

Flerie AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 0.000 100.225 0.000
201509 -9.995 100.228 -13.246
201512 -9.054 100.276 -11.993
201603 15.608 100.751 20.577
201606 -10.383 101.019 -13.652
201609 -9.372 101.138 -12.308
201612 -17.143 102.022 -22.319
201703 -11.457 102.022 -14.916
201706 -11.052 102.752 -14.287
201709 -9.950 103.279 -12.796
201712 -7.911 103.793 -10.124
201803 -13.741 103.962 -17.556
201806 -11.797 104.875 -14.941
201809 -9.634 105.679 -12.109
201812 -10.870 105.912 -13.632
201903 -10.024 105.886 -12.574
201906 -7.514 106.742 -9.350
201909 -10.121 107.214 -12.539
201912 -14.558 107.766 -17.943
202003 -9.265 106.563 -11.548
202006 -16.570 107.498 -20.474
202009 -3.240 107.635 -3.998
202012 -3.208 108.296 -3.935
202103 -1.782 108.360 -2.184
202106 -8.452 108.928 -10.306
202109 -4.691 110.338 -5.647
202112 -9.346 112.486 -11.036
202203 -3.459 114.825 -4.001
202206 -9.750 118.384 -10.939
202209 -4.471 122.296 -4.856
202212 -6.419 126.365 -6.747
202303 -4.345 127.042 -4.543
202306 15.109 129.407 15.508
202309 0.051 130.224 0.052
202312 -0.179 131.912 -0.180
202403 -0.030 132.205 -0.030
202406 -0.266 132.716 -0.266
202409 -0.068 132.304 -0.068
202412 0.094 132.987 0.094
202503 -0.233 132.825 -0.233

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Flerie AB  (OSTO:FLERIE) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Flerie AB Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Flerie AB's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Flerie AB Business Description

Industry
Traded in Other Exchanges
Address
Skeppsbron 16, Stockholm, SWE, 111 30
Flerie AB is a pharmaceutical company focusing on immunological diseases with great medical needs for new treatment options. The portfolio of the company includes Immuno-Oncology, metabolic diseases, and biologics development and manufacturing organizations.

Flerie AB Headlines

No Headlines